Related Experiment Video
Updated: Jun 19, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Natural products targeting ferroptosis pathways in cancer therapy (Review)
Xin Na1, Lin Li2, Dongmei Liu1
1School of Pharmaceutical Sciences & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Abstract:
Ferroptosis inducers (FIN) have a key role in cancer therapy and provide novel and innovative treatment strategies. Although many researchers have performed FIN screening of synthetic compounds, studies on the identification of FIN from natural products are limited, particularly in the field of drug development and combination therapy. In this review, this gap was addressed by comprehensively summarizing recent studies on ferroptosis. The causes of ferroptosis were categorized into driving and defensive factors, elucidating key pathways and targets. Next, through summarizing research on natural products that induce ferroptosis, the study elaborated in detail on the natural products that have FIN functions. Their discovery and development were also described and insight for clinical drug development was provided. In addition, the mechanisms of action were analyzed and potential combination therapies, resistance reversal and structural enhancements were presented. By highlighting the potential of natural products in inducing ferroptosis for cancer treatment, this review may serve as a reference for utilizing these compounds against cancer. It not only showed the significance of natural products but may also promote further investigation into their therapeutic effects, thus encouraging research in this field.
Insights
Natural products that induce ferroptosis (FIN) offer novel cancer treatment strategies. This review details FIN from natural sources, their mechanisms, and potential for drug development and combination therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Ferroptosis inducers (FIN) are crucial for innovative cancer therapies.
- Research on natural product-derived FIN is limited, especially for drug development and combination therapy.
Purpose of the Study:
- To comprehensively review recent studies on ferroptosis.
- To identify and elaborate on natural products with FIN functions.
- To provide insights into clinical drug development, combination therapies, and resistance reversal.
Main Methods:
- Categorization of ferroptosis causes into driving and defensive factors.
- Elucidation of key ferroptosis pathways and targets.
- Summarization and analysis of research on natural products inducing ferroptosis.
Main Results:
- Key pathways and targets of ferroptosis were identified.
- Natural products with ferroptosis-inducing functions were detailed.
- Mechanisms of action, combination therapies, and resistance reversal strategies were analyzed.
Conclusions:
- Natural products hold significant potential for cancer treatment via ferroptosis induction.
- This review serves as a reference for utilizing natural compounds against cancer.
- Further investigation into the therapeutic effects of natural FIN is encouraged.
More Related Videos
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

